Recent Transactions

05-Oct-16
$775 million
U.K., Ireland flags
Target: 

Assets and operations of Actavis Generics in the UK and Ireland from Teva Pharmaceutical Industries Ltd.

India flag
Acquiror: 
Accord Healthcare Ltd.

Advised Teva Pharmaceutical Industries Ltd., the world’s largest generic drug company, on its sale of assets and operations of Actavis Generics in the UK and Ireland to Accord Healthcare Ltd. (a subsidiary of Intas Pharmaceuticals Limited) for £603m (c.$775m) 

05-Oct-16
$NA
Israel flag
Target: 

Portfolio of 14 Outlicensing generic products in the EEA from Teva Pharmaceutical Industries Ltd.

India flag
Acquiror: 
Accord Healthcare Ltd.

Advised Teva Pharmaceutical Industries Ltd., the world’s largest generic drug company, on the divestment of a portfolio of 14 Outlicensing pharmaceutical products in the EEA to Accord Healthcare Ltd. (a subsidiary of Intas Pharmaceuticals Limited).

20-Jun-16
$NA
Israel flag
Target: 

US rights to 2 generic drug products from Teva Pharmaceutical Industries Ltd.

India flag
Acquiror: 
Zydus Cadila

Advised Teva Pharmaceutical Industries Ltd. on the divestment of the US rights to 2 generic drug products to Zydus Cadila

11-Jun-16
$350 million
Israel flag
Target: 

US rights to 8 generic drug products from Teva Pharmaceutical Industries Ltd.

India flag
Acquiror: 
Dr. Reddy’s Laboratories

Advised Teva Pharmaceutical Industries Ltd. on the divestment of the US rights to 8 generic drug products to Dr. Reddy’s Laboratories

20-Aug-15
$1.0 billion
China flag
Target: 

COOEC Fluor Heavy Industries Co., Ltd.

United States flag
Acquiror: 
Fluor Corporation

Advised Fluor Corporation on its $489 million investment for a 49% interest in a joint venture with Offshore Oil Engineering Co., Ltd. (COOEC) to own, operate and manage the Zhuhai Fabrication Yard in China’s Guangdong province

27-Jul-15
$40.5 billion
Ireland flag
Target: 

Allergan Generics

Israel flag
Acquiror: 
Teva Pharmaceutical Industries Ltd.

Advised Teva Pharmaceutical Industries Ltd., a leading global pharmaceutical company, on the acquisition of Allergan plc’s Generics business

02-Mar-15
$107 million
Japan, Australia flags
Target: 

Lion's Everyday Cheese Business

Australia flag
Acquiror: 
Warrnambool Cheese & Butter

Advised Lion, a leading Australasian food and beverage company wholly owned by Japanese conglomerate Kirin, on the sale of its Everyday Cheese business to Warrnambool Cheese & Butter, a listed Australian dairy company controlled by the Canadian dairy player Saputo

19-Dec-14
$NA
United States flag
Target: 

NYK Ports LLC

Australia flag
Acquiror: 
Macquarie Infrastructure Partners

Advised NYK Ports LLC, a leading port operating and stevedoring company, on the sale of a 49% stake to Macquarie Infrastructure Partners, a leading Australian infrastructure fund

21-Nov-14
$203 million
Japan flag
Target: 

Tipness Limited

Japan flag
Acquiror: 
Nippon Television Holdings

Advised Nippon Television Holdings, a media and content company engaged in production and broadcasting primarily in Japan, on the acquisition of Tipness Limited, the fourth largest fitness club company in Japan,  from Suntory Holdings and Marubeni Corporation

01-Oct-14
$NA
Australia flag
Target: 

Modern Star Pty Ltd

Malaysia flag
Acquiror: 
Navis Capital

Advised Modern Star, Australia and New Zealand’s #1 supplier of education resources and educational toys, on the sale of 90% of its shares to Navis Capital, a leading private equity group focused on investments in South and Southeast Asia

05-Feb-14
$NA
Sweden flag
Target: 

Unfors Raysafe AB

United States flag
Acquiror: 
Fluke Biomedical Corporation

Advised the Sixth Swedish National Pension Fund on the sale of Unfors Raysafe AB, a provider of easy-to-use products that help to reduce unnecessary radiation exposure, to Fluke Biomedical Corp., a subsidiary of Danaher Corp. that manufactures biomedical test and simulation products

09-Dec-13
$NA
ASEAN flag
Target: 

Lazada Group GmbH

United Kingdom flag
Acquiror: 
Tesco plc

Advised Tesco plc, a listed FTSE 100 retailer, on its acquisition of a significant minority shareholding in Lazada, the leading online general merchandise retailer in South East Asia

04-Dec-13
$850 million
Russia flag
Target: 

Megapolis Distribution

Japan flag
Acquiror: 
Japan Tobacco Inc

Advised Japan Tobacco Inc in connection with the acquisition of a minority stake in Megapolis Distribution B.V., Russia’s leading tobacco distributor

02-Oct-13
$NA
United Kingdom flag
Target: 

Tesco PLC's Chinese retail operations

China flag
Acquiror: 
China Resources Enterprise

Advised Tesco PLC on the formation of a joint venture with China Resources Enterprise, a Hong Kong listed, Chinese retailer, to create the leading multi-format retailer in China

09-Sep-13
$2.1 billion
United Kingdom flag
Target: 

Lucozade & Ribena brands (owned by GSK)

Japan flag
Acquiror: 
Suntory Beverage & Food Ltd

Advised GlaxoSmithKline, the UK listed international pharmaceutical and consumer company, on the sale of its nutritional drinks brands Lucozade and Ribena to Suntory Beverage & Food Ltd

26-Apr-13
$NA
Japan flag
Target: 

Yakult Honsha

France flag
Acquiror: 
Danone

Advised Danone, a world leading food company, on its business and capital alliance with Yakult Honsha, the largest probiotic dairy product manufacturer in Japan

20-Dec-12
$NA
Germany flag
Target: 

Germanischer Lloyd

Norway flag
Acquiror: 
Det Norske Veritas

Advised Det Norske Veritas on its merger with Germanischer Lloyd to create the third largest player in the Testing, Inspection and Certification industry, focused on ship classification, oil & gas and energy

07-Dec-12
$43 million
New Zealand flag
Target: 

Champion Flour Limited

Japan flag
Acquiror: 
Nisshin Seifun Group Inc.

Advised Goodman Fielder, a leading Australian listed food company, on the sale of its New Zealand flour milling business, Champion Flour, to Nisshin Seifun Group Inc.

24-Aug-12
$674 million
Japan flag
Target: 

ITX (Mobile Phone Retailing Business)

Japan flag
Acquiror: 
Japan Industrial Partners

Advised Japan Industrial Partners, a leading private equity firm in Japan, on the acquisition of mobile phone retailing business from ITX, a mobile phones marketer and distributor in Japan

18-Jun-12
$386 million
Australia flag
Target: 

Little World Beverages

Australia, Japan flags
Acquiror: 
Lion / Kirin

Advised Lion on the acquisition of Little World Beverages, Australia’s largest listed brewer and one of the country’s leading players in the Craft beer segment

30-Jun-11
$609 million
Japan flag
Target: 

Diabetes-related patent estate and royalty stream of Astellas Pharma subsidiary, Prosidion

United States flag
Acquiror: 
Royalty Pharma

Advised Royalty Pharma, a leading acquiror of biopharmaceutical royalty interests, on the acquisition of the DPP-IV patent estate and associated royalty stream of Astellas Pharma subsidiary, Prosidion

06-May-11
$NA
Norway flag
Target: 

Aker Solutions (Aker Holding)

Norway flag
Acquiror: 
Norwegian Government

Advised the Norwegian Government on strategic and financial matters in relation to its investment in Aker Holding, the largest shareholder of Aker Solutions during the demerger of the company’s EPC activities

13-Apr-11
$NA
Australia flag
Target: 

Retail Apparel Group

Malaysia flag
Acquiror: 
Navis Capital

Advised CHAMP Ventures on the sale of its portfolio company Retail Apparel Group, an Australian based men’s specialty apparel retailer, to Navis Capital, one of the largest regional private equity business in south-east Asia

24-Dec-10
$NA
New Zealand flag
Target: 

Tegel Foods Limited

Hong Kong flag
Acquiror: 
Affinity Equity Partners

Advised Pacific Equity Partners and ANZ, the shareholders of Tegel Foods (Tegel), on the sale of Tegel, New Zealand’s preeminent producer of poultry products, to Affinity Equity Partners

21-Sep-10
$234 million
Israel flag
Target: 

Taro Pharmaceutical Industries

India flag
Acquiror: 
Sun Pharmaceutical Industries Ltd.

Advised Sun Pharmaceutical Industries Ltd., the largest Indian pharmaceutical company by market capitalization, on its acquisition of a majority interest in Israeli based Taro Pharmaceutical Industries, a multinational generics pharmaceutical company

Pages

show all